These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22336669)

  • 1. Additional diffusion-weighted imaging in the detection of new, very small hepatocellular carcinoma lesions after interventional therapy compared with conventional 3 T MRI alone.
    Qu JR; Li HL; Shao NN; Li X; Yan GL; Zhang HK; Luo JP; Zhang SN; Li YL; Liu CC
    Clin Radiol; 2012 Jul; 67(7):669-74. PubMed ID: 22336669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial?
    Zhao XT; Li WX; Chai WM; Chen KM
    J Dig Dis; 2014 Mar; 15(3):137-45. PubMed ID: 24354621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas.
    Yu JS; Kim JH; Chung JJ; Kim KW
    J Magn Reson Imaging; 2009 Jul; 30(1):153-60. PubMed ID: 19557734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of small intrahepatic metastases of hepatocellular carcinomas using diffusion-weighted imaging: comparison with conventional dynamic MRI.
    Yu JS; Chung JJ; Kim JH; Cho ES; Kim DJ; Ahn JH; Kim KW
    Magn Reson Imaging; 2011 Sep; 29(7):985-92. PubMed ID: 21616624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI.
    Chung J; Yu JS; Kim DJ; Chung JJ; Kim JH; Kim KW
    Magn Reson Imaging; 2011 Nov; 29(9):1235-43. PubMed ID: 21907517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added value of diffusion-weighted MRI for evaluating viable tumor of hepatocellular carcinomas treated with radiotherapy in patients with chronic liver disease.
    Park HJ; Kim SH; Jang KM; Lim S; Kang TW; Park HC; Choi D
    AJR Am J Roentgenol; 2014 Jan; 202(1):92-101. PubMed ID: 24370133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)-enhanced MRI: Added value of diffusion-weighted imaging (DWI).
    Nishie A; Tajima T; Ishigami K; Ushijima Y; Okamoto D; Hirakawa M; Nishihara Y; Taketomi A; Hatakenaka M; Irie H; Yoshimitsu K; Honda H
    J Magn Reson Imaging; 2010 Feb; 31(2):373-82. PubMed ID: 20099351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver.
    Le Moigne F; Durieux M; Bancel B; Boublay N; Boussel L; Ducerf C; Berthezène Y; Rode A
    Magn Reson Imaging; 2012 Jun; 30(5):656-65. PubMed ID: 22459435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.
    Piana G; Trinquart L; Meskine N; Barrau V; Beers BV; Vilgrain V
    J Hepatol; 2011 Jul; 55(1):126-32. PubMed ID: 21145857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pooled analysis of diffusion-weighted imaging in the diagnosis of hepatocellular carcinoma in chronic liver diseases.
    Wu LM; Xu JR; Lu Q; Hua J; Chen J; Hu J
    J Gastroenterol Hepatol; 2013 Feb; 28(2):227-34. PubMed ID: 23190006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma.
    Kim YK; Kim YK; Park HJ; Park MJ; Lee WJ; Choi D
    Magn Reson Imaging; 2014 Jul; 32(6):610-8. PubMed ID: 24702980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
    Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
    J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of peritoneal tumor imaging using conventional MR imaging and diffusion-weighted MR imaging with different b values.
    Bozkurt M; Doganay S; Kantarci M; Yalcin A; Eren S; Atamanalp SS; Yuce I; Yildirgan MI
    Eur J Radiol; 2011 Nov; 80(2):224-8. PubMed ID: 20598823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvascular invasion in small hepatocellular carcinoma: is it predictable with preoperative diffusion-weighted imaging?
    Xu P; Zeng M; Liu K; Shan Y; Xu C; Lin J
    J Gastroenterol Hepatol; 2014 Feb; 29(2):330-6. PubMed ID: 24033853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3 T MRI of hepatocellular carcinomas in patients with cirrhosis: does T2-weighted imaging provide added value?
    Guo L; Liang C; Yu T; Wang G; Li N; Sun H; Gao F; Liu C
    Clin Radiol; 2012 Apr; 67(4):319-28. PubMed ID: 22099524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
    Goshima S; Kanematsu M; Kondo H; Yokoyama R; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
    J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does diffusion-weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd-EOB-DTPA with and without DWI.
    Schelhorn J; Best J; Reinboldt MP; Dechêne A; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
    J Magn Reson Imaging; 2015 Sep; 42(3):818-27. PubMed ID: 25515676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.